touchONCOLOGY were honoured to meet Denis Lacombe, Director General, European Organisation for Research and Treatment of Cancer (EORTC), at the ECCO 2019 European Cancer Summit in Brussels to discuss the latest exciting updates in clinical cancer research across Europe: do we need to change tracks?
1. What are the key recent advances in clinical cancer research in Europe – how will they impact treatments for patients? (0:08)
2. How has the development of anti-cancer treatments changed in recent years and how is it continuing to change? (0:40)
3. Despite recent advances, is the current clinical research in cancer in Europe addressing the right issues or pursuing the right targets? (1:38)
4. What is the European Organisation for Research and Treatment of Cancer (EORTC) doing to address the difficulties in developing new cancer therapies and make them available to patients more quickly? (2:38)
5. Given the ongoing pace of progress of clinical cancer research and treatment developments, do you feel optimistic that the prognosis for many patients with cancer is improving and will it continue to do so into the future? (3:44)
Denis Lacombe has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Stefan Gijssels, Eureopean Cancer Summit 2020 – The Beating Cancer Plan
touchONCOLOGY means Stefan Gijssels at the European Cancer Summit 2020 to discuss the Beating Cancer Plan and key highlights and outcomes from this year’s meeting. Questions How do you expect the cancer burden in Europe to change in the coming years? What are the aims and main components of the Beating Cancer Plan? What initiatives […]
Françoise Meunier, European Cancer Summit 2020 – Financial Toxicity and the ‘Right to be Forgotten’
Dr Françoise Meunier, Vice President of the Federation of European Academies of Medicine, joins touchONCOLOGY to discuss financial toxicity in patients with cancer and progress made with the “Right to be Forgotten” resolution made at the European Cancer Summit in 2018. Questions What does the term ‘financial toxicity’ mean, and what does it mean for […]
Daniel Kelly, European Cancer Summit 2020 – HPV Action Network
touchONCOLOGY joins Prof. Daniel Kelly to discuss the aims and scope of the European Cancer Organisation HPV Action Network. Questions What are the aims of the HPV Action Network? How can HPV-associated cancers be reduced and why is this resolution important? Could you tell us about the European Cancer Organisation’s recent action plan and report, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!